
BCTX Valuation
Briacell Therapeutics Corp
- Overview
- Forecast
- Valuation
- Earnings
BCTX Relative Valuation
BCTX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BCTX is overvalued; if below, it's undervalued.
Historical Valuation
Briacell Therapeutics Corp (BCTX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.35. The fair price of Briacell Therapeutics Corp (BCTX) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:0.80
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.42
P/B
Median3y
-7.68
Median5y
0.42
-449.02
FCF Yield
Median3y
-76.55
Median5y
-51.96
Competitors Valuation Multiple
The average P/S ratio for BCTX's competitors is 4.04, providing a benchmark for relative valuation. Briacell Therapeutics Corp Corp (BCTX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
People Also Watch

BWLP
BW LPG Ltd
13.720
USD
-1.51%

BEP
Brookfield Renewable Partners LP
27.240
USD
-0.58%

BUR
Burford Capital Ltd
13.780
USD
-0.79%

BTG
B2Gold Corp
3.470
USD
-1.42%

BKT
Blackrock Income Trust Inc
11.640
USD
+0.17%

CGC
Canopy Growth Corp
1.140
USD
+2.70%

CGABL
The Carlyle Group Inc. 4.625% Subordinated Notes Due 2061
17.820
USD
+0.45%

CGBDL
Carlyle Secured Lending Inc
26.170
USD
+1.00%

BHFAL
Brighthouse Financial Inc
18.650
USD
+0.16%

CGAU
Centerra Gold Inc
7.350
USD
-1.21%
FAQ

Is Briacell Therapeutics Corp (BCTX) currently overvalued or undervalued?
Briacell Therapeutics Corp (BCTX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.35. The fair price of Briacell Therapeutics Corp (BCTX) is between to according to relative valuation methord.

What is Briacell Therapeutics Corp (BCTX) fair value?

How does BCTX's valuation metrics compare to the industry average?

What is the current P/B ratio for Briacell Therapeutics Corp (BCTX) as of Jul 27 2025?

What is the current FCF Yield for Briacell Therapeutics Corp (BCTX) as of Jul 27 2025?

What is the current Forward P/E ratio for Briacell Therapeutics Corp (BCTX) as of Jul 27 2025?
